FDA Approves New Blood Test for Colon Cancer Screening
Today, the Food and Drug Administration (FDA) granted approval for Guardant Health’s new blood test, Shield, to screen for colon cancer. This decision could significantly impact the rate of screenings for the second-highest cause of cancer deaths in the U.S. The test is designed for